HDEF - ETF AI Analysis

Top Page

Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)

Rating:68Neutral

Price Target:―

HDEF, the Xtrackers MSCI EAFE High Dividend Yield Equity ETF, earns a solid overall rating thanks to several high-quality, dividend-focused holdings with strong financial performance and generally reasonable valuations. Standout positions like Novartis, TotalEnergies, and Zurich Insurance support the fund with robust profitability, positive earnings sentiment, and attractive income potential, while stable consumer names like Nestlé and Unilever add defensive balance. The main risks come from some holdings showing bearish or overbought technical signals and the fund’s concentration in a relatively small group of large non-U.S. companies, which can increase sensitivity to sector and regional market swings.

Positive Factors

Strong Leading Holdings

Several of the largest positions, such as Roche and Novartis, have shown solid gains this year, helping support the fund’s overall results.

Low Expense Ratio

The fund charges a relatively low fee, which means more of the dividend income and price gains can stay in investors’ pockets over time.

Broad International Diversification

Exposure across many developed markets outside the U.S., including Switzerland, the UK, France, Germany, and Japan, helps spread country-specific risk.

Negative Factors

Mixed Recent Performance

The ETF’s year-to-date return has been slightly negative, showing that it has struggled to gain steady upward momentum so far this year.

Concentration in a Few Countries

A large share of assets is concentrated in Switzerland and the UK, which increases the impact that economic or political issues in those markets can have on the fund.

Heavy Tilt to Financials and Defensives

Significant weight in financial, consumer defensive, and utility stocks may cause the fund to lag when more growth-oriented or technology sectors lead the market.

HDEF vs. SPDR S&P 500 ETF (SPY)

AUM2.27B

RegionDeveloped Markets

Expense Ratio0.09%

Beta0.44

IssuerXtrackers

Inception DateAug 12, 2015

Dividend Yield3.75%

Asset ClassEquity

Index TrackedMSCI EAFE High Dividend Yield

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume323,207

30 Day Avg. Volume192,588

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

33.58

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering111

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

HDEF Summary

HDEF is an ETF that follows the MSCI EAFE High Dividend Yield Index, focusing on companies in developed markets outside the U.S. and Canada, such as Europe and Japan. It mainly holds large, established businesses that pay relatively high dividends, including well-known names like Nestlé and Shell. Investors might consider HDEF if they want international diversification and a potential income stream from dividends rather than just growth. A key risk is that the fund is concentrated in foreign and dividend-focused stocks, so its value and income can go up and down with global markets and interest-rate changes.

How much will it cost me?The expense ratio for HDEF is 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because HDEF is passively managed, tracking an index rather than relying on active stock selection.

What would affect this ETF?HDEF could benefit from stable dividend payouts and growth in developed markets outside North America, especially if sectors like financials and healthcare, which have significant weight in the ETF, perform well. However, challenges such as rising interest rates, economic slowdowns in Europe or Asia, or regulatory changes affecting top holdings like Novartis or Shell could negatively impact returns. Diversification across sectors and regions provides some resilience, but global economic conditions remain a key factor to watch.

HDEF Top 10 Holdings

HDEF leans heavily on Europe’s defensive giants, with Swiss pharma leaders Roche and Novartis doing much of the heavy lifting as their shares keep rising on solid pipelines and dependable cash flows. Consumer staples like Nestlé and Unilever add a steady, dividend-rich backbone, recently perking up after a quieter stretch. On the energy side, TotalEnergies and Shell are giving the fund an extra boost, while insurers Allianz and Zurich are more of a mixed bag, lagging a bit. Overall, it’s a developed-markets ex-U.S. income play, anchored in Europe’s mature, dividend-heavy sectors.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NOVN	Novartis AG	5.62%	$126.52M	CHF229.98B	24.67%	80 Outperform
SHEL	Shell (UK)	5.48%	$123.54M	£187.41B	27.85%	73 Outperform
ROG	Roche Holding AG	5.33%	$120.10M	CHF254.35B	25.81%	73 Outperform
NESN	Nestlé SA	4.77%	$107.49M	CHF202.39B	2.00%	71 Outperform
TTE	TotalEnergies SE	4.15%	$93.39M	€150.58B	27.15%	78 Outperform
ALV	Allianz	3.95%	$89.07M	€132.73B	0.51%	67 Neutral
IBE	Iberdrola	3.73%	$83.98M	€130.51B	41.04%	67 Neutral
ULVR	Unilever	3.62%	$81.43M	£105.49B	―	72 Outperform
BATS	British American Tobacco	3.33%	$75.00M	£96.42B	39.44%	71 Outperform
ZURN	Zurich Insurance Group	2.57%	$57.80M	CHF79.83B	-1.21%	78 Outperform

HDEF Technical Analysis

Technical Analysis Sentiment

Neutral

Last Price―

Price Trends

50DMA

32.34

Negative

100DMA

31.23

Positive

200DMA

30.04

Positive

Market Momentum

MACD

-0.12

Positive

RSI

36.99

Neutral

STOCH

19.04

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HDEF, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 33.16, equal to the 50-day MA of 32.34, and equal to the 200-day MA of 30.04, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 36.99 is Neutral, neither overbought nor oversold. The STOCH value of 19.04 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HDEF.

HDEF Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
HDEF	―	―	$2.27B	0.09%	68 Neutral
IDV	―	―	$7.87B	0.50%	58 Neutral
DIVI	―	―	$2.31B	0.09%	66 Neutral
DTH	―	―	$635.71M	0.58%	62 Neutral
FIDI	―	―	$287.77M	0.18%	66 Neutral
EFAS	―	―	$43.16M	0.55%	55 Neutral

Performance Comparison

HDEF

Xtrackers MSCI EAFE High Dividend Yield Equity ETF

32.04

5.74

21.83%

IDV

iShares International Select Dividend ETF

―

DIVI

Franklin LibertyQ International Equity Hedged ETF

―

DTH

WisdomTree International High Dividend Fund

―

FIDI

Fidelity International High Dividend ETF

―

EFAS

Global X MSCI SuperDividend EAFE ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents